Fulgent Genetics’ Post

Today is Rare Disease Day. For 3 million Canadians, the reality of having a rare disease in this country has many challenges https://lnkd.in/gYjS6whf #rarediseaseday #specialtypharmaceuticals #Canada #pharmaceuticalindustry #raredisease #rareconditions #oncology #precisiononcology #patientsfirst #marketaccess #innovativeagreements #innovativecontracting 

The countdown is on! In just a few days we will be launching something BIG. And we can’t wait to tell you all about it! Keep your eyes in the skies, friends (ok, maybe just on LinkedIn for now). #staytuned #launch #blastoff #countdown #healthcare2024 #biopharma #marketaccess #patientaccess #cellandgenetherapy #geneandcelltherapy #celltherapy #genetherapy #cgt #oncology #raredisease #rarediseases

🔬Uncover valuable insights into strategic oncology clinical trial design in Caidya's upcoming webinar! 🌐 Dive deep into the pivotal role trial design plays in early #oncology studies, exploring novel approaches like biomarker stratification, adaptive enrichment designs and real-world data integration under Project Optimus. 🔗 Register and learn more here: https://buff.ly/3Se8uDE #ClinicalData #OncologyClinicalTrials #ClinicalTrialDesign #EarlyPhaseTrials

Today is International Rare Disease Day - a day that promotes healthcare equity, opportunities, and treatment access for those living with rare diseases. Check out the report from 20Sense below ⬇️ Nicole Serena #RareDiseaseDay #RareDiseases #PatientSupport #Healthcare

The World Health Organization states that cancer cases continue to increase globally, and estimate 35million new cases by 2050, a 77% increase from the 22million in 2022. Researchers in #Academia, #Biotech and #BioPharma continue the challenge to find life-extending, and even curable treatments for one of the most prevalent diseases on earth. Inizio is one of the most experienced #oncology partners to the life sciences industry; as our CEO Paul Taaffe states, our expertise is 'unrivalled' and here are the stats to prove it: ✔ partnered on 60% of all oncology launches in the last 2 years ✔ partnered on 78 assets in pivotal clinical trials in 2023 ✔ partnered on 148 oncology assets in 2023, including 91 small molecule assets Want to learn more about how we can support #development, #commercialization, #productlaunch and more? Get in touch 📧 #ReimagineHealth #ConnectedCapabilities #Inizio Inizio Advisory I Inizio Medical I Inizio Evoke I Inizio Engage

125,070 is too many. Together, we can make a difference and change the statistic. SciTech's new Drug Delivery Platform and lead drug candidate, are a major step forward. Learn more about our research and how you can support our mission. #WorldLungCancerDay #CancerCure #JoinTheFight #scitechSDP #scitechdevelopment #oncology #nanofenretinide #fenretinide #lymphoma #nonhodgkin #drugdelivery #ST001

Originating in the 1950s, the industry understanding and use of biomarkers in healthcare has changed dramatically in recent years. 2021 alone saw over 27,000 research publications that use the term "biomarker" in the title or abstract, compared to just 760 in 2003. Learn more about the history and applications of biomarkers in our recent publication: https://lnkd.in/gmiig3zx #Oncology #RWD #Healthcare

On #WorldCancerResearchDay, we join the global community in recognizing the critical efforts to fight cancer and honoring the collective contributions of patients, families, doctors, and researchers. We are proud to continue advancing our research dedicated to addressing unmet needs in the treatment of complex diseases including #prostatecancer and #CMML. To learn more about our #oncology programs and ongoing research, visit: https://lnkd.in/efAFUfRh #CyTACPlatform #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine #Oncology

How would we describe Molecular Partners in one word? Pioneers.    We are the inventors and developers of #DARPin therapeutics – an entirely new class of custom-built drugs – with the goal of transforming the lives of patients with serious diseases.     #RadioDARPins #cancerresearch #oncology #radiopharmaceuticals

There are so many nuances when it comes to different settings of care. Each setting has its own challenges and opportunities that can have a major impact on provider uptake. From having the right decision-makers at the table to understanding the unique complexities and processes across settings, the details can make or break a launch. Learn more in this fun, quick video from our very own experts, Timothy Miller and Marysia Cole. #biopharma #marketaccess #patientaccess #druglaunch #oncology #raredisease #cellandgenetherapy #celltherapy #genetherapy #complexconditions #rarediseases #launchsuccess #pharmalaunch #biopharmalaunch